Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Paul Viard

Showing results (81-90 of 131) with videos related to

Pageof 14
Sort By:
Plos One|August 13, 2013
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohortsEvguenia Krastinova, Remonie Seng, Patrick Yeni, et al.
AIDS Research and Human Retroviruses|October 20, 2020
Prevalence of Silent Atherosclerosis and Other Comorbidities in an Outpatient Cohort of Adults Living with HIV: Associations with HIV Parameters and BiomarkersJade Ghosn, Hendy Abdoul, Soraya Fellahi, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapyWendy P Bannister, Alessandro Cozzi-Lepri, Jesper Kjær, et al.
Antiviral Therapy|September 6, 2008
Incidence of abacavir hypersensitivity reactions in euroSIDAWendy P Bannister, Nina Friis-Møller, Amanda Mocroft, et al.
Open Forum Infectious Diseases|May 9, 2017
Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP StudyJosiane Warszawski, Véronique Avettand-Fenoel, Christine Rouzioux, et al.
Plos One|December 10, 2015
Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP StudyJérôme Le Chenadec, Daniel Scott-Algara, Stéphane Blanche, et al.
AIDS Research and Human Retroviruses|September 16, 2016
Gag-Specific CD4 T Cell Proliferation, Plasmacytoid Dendritic Cells, and Ethnicity in Perinatally HIV-1-Infected Youths: The ANRS-EP38-IMMIP StudyDaniel Scott-Algara, Josiane Warszawski, Jérôme Le Chenadec, et al.
AIDS (London, England)|April 28, 2011
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA studyJean-Paul Viard, Jean-Claude Souberbielle, Ole Kirk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2022
Decrease in CD4 T-Cell Count and Risk of Severe Morbid Conditions in People With Human Immunodeficiency Virus Infection With Controlled Viral Load After Initiating Combination Antiretroviral Therapy Between 2006 and 2018Maria Choufany, Laurence Weiss, Alain Makinson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across EuropeWendy P Bannister, Ole Kirk, Jose M Gatell, et al.
Pageof 14

Showing results (81-90 of 131) with videos related to

Sort By:
Pageof 14
Plos One|August 13, 2013
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohortsEvguenia Krastinova, Remonie Seng, Patrick Yeni, et al.
AIDS Research and Human Retroviruses|October 20, 2020
Prevalence of Silent Atherosclerosis and Other Comorbidities in an Outpatient Cohort of Adults Living with HIV: Associations with HIV Parameters and BiomarkersJade Ghosn, Hendy Abdoul, Soraya Fellahi, et al.
The Journal of Antimicrobial Chemotherapy|March 12, 2011
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapyWendy P Bannister, Alessandro Cozzi-Lepri, Jesper Kjær, et al.
Antiviral Therapy|September 6, 2008
Incidence of abacavir hypersensitivity reactions in euroSIDAWendy P Bannister, Nina Friis-Møller, Amanda Mocroft, et al.
Open Forum Infectious Diseases|May 9, 2017
Gag-Specific CD8 T-Cell Proliferation Is Associated With Higher Peripheral Blood Levels of Transforming Growth Factor-β and Gut-Homing T Cells in Youths Perinatally Infected With Human Immunodeficiency Virus-1: The ANRS-EP38-IMMIP StudyJosiane Warszawski, Véronique Avettand-Fenoel, Christine Rouzioux, et al.
Plos One|December 10, 2015
Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP StudyJérôme Le Chenadec, Daniel Scott-Algara, Stéphane Blanche, et al.
AIDS Research and Human Retroviruses|September 16, 2016
Gag-Specific CD4 T Cell Proliferation, Plasmacytoid Dendritic Cells, and Ethnicity in Perinatally HIV-1-Infected Youths: The ANRS-EP38-IMMIP StudyDaniel Scott-Algara, Josiane Warszawski, Jérôme Le Chenadec, et al.
AIDS (London, England)|April 28, 2011
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA studyJean-Paul Viard, Jean-Claude Souberbielle, Ole Kirk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2022
Decrease in CD4 T-Cell Count and Risk of Severe Morbid Conditions in People With Human Immunodeficiency Virus Infection With Controlled Viral Load After Initiating Combination Antiretroviral Therapy Between 2006 and 2018Maria Choufany, Laurence Weiss, Alain Makinson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 2006
Regional changes over time in initial virologic response rates to combination antiretroviral therapy across EuropeWendy P Bannister, Ole Kirk, Jose M Gatell, et al.
Pageof 14